Cargando…

Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study

OBJECTIVE: To assess the prevalence and factors associated with modern contraceptive (CP) use among women of the reproductive age. DESIGN: Cross-sectional study. SETTING: We used data from the Multiple Indicator Cluster Surveys (MICSs) from 20 African countries collected between 2013 and 2018. PARTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Apanga, Paschal Awingura, Kumbeni, Maxwell Tii, Ayamga, Emmanuel Awine, Ulanja, Mark B, Akparibo, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520862/
https://www.ncbi.nlm.nih.gov/pubmed/32978208
http://dx.doi.org/10.1136/bmjopen-2020-041103
_version_ 1783587862686466048
author Apanga, Paschal Awingura
Kumbeni, Maxwell Tii
Ayamga, Emmanuel Awine
Ulanja, Mark B
Akparibo, Robert
author_facet Apanga, Paschal Awingura
Kumbeni, Maxwell Tii
Ayamga, Emmanuel Awine
Ulanja, Mark B
Akparibo, Robert
author_sort Apanga, Paschal Awingura
collection PubMed
description OBJECTIVE: To assess the prevalence and factors associated with modern contraceptive (CP) use among women of the reproductive age. DESIGN: Cross-sectional study. SETTING: We used data from the Multiple Indicator Cluster Surveys (MICSs) from 20 African countries collected between 2013 and 2018. PARTICIPANTS: Data on 1 177 459 women aged 15–49 years old. METHODS: Multivariable logistic regression was used to identify factors associated with modern CP use, while controlling simultaneously for independent variables, and accounting for clustering, stratification and sample weights from the complex sampling design. We used random effects meta-analysis to pool adjusted estimates across the 20 countries. RESULTS: The overall prevalence of modern CP use was 26% and ranged from 6% in Guinea to 62% in Zimbabwe. Overall, injectable (32%) was the most preferred method of CP, followed by oral pill (27%) and implants (16%). Women were more likely to use a modern CP if they: had a primary (adjusted prevalence odds ratios (aPORs): 1.68, 95% CI: 1.47 to 1.91)) or secondary/higher education (aPOR: 2.16, 95% CI: 1.80 to 2.59) compared with women with no formal education; had no delivery in the last 2 years (aPOR: 3.89, 95% CI: 2.76 to 5.47) compared with women who delivered in the last 2 years; were aged 25–34 years (aPOR: 1.33, 95% CI: 1.20 to 1.47) compared with women aged 15–24 years; were of middle-income status (aPOR: 1.25, 95% CI: 1.11 to 1.39) or rich (aPOR: 1.53, 95% CI: 1.27 to 1.84) compared with poor women and had two or more antenatal care visits compared with women without a visit. Perceived domestic violence was not associated with modern CP use (aPOR: 0.98, 95% CI: 0.92 to 1.05). CONCLUSION: Our findings are relevant in a global context, particularly in the African region, and improve our understanding on relevant factors essential to increasing modern CP use.
format Online
Article
Text
id pubmed-7520862
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75208622020-10-14 Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study Apanga, Paschal Awingura Kumbeni, Maxwell Tii Ayamga, Emmanuel Awine Ulanja, Mark B Akparibo, Robert BMJ Open Global Health OBJECTIVE: To assess the prevalence and factors associated with modern contraceptive (CP) use among women of the reproductive age. DESIGN: Cross-sectional study. SETTING: We used data from the Multiple Indicator Cluster Surveys (MICSs) from 20 African countries collected between 2013 and 2018. PARTICIPANTS: Data on 1 177 459 women aged 15–49 years old. METHODS: Multivariable logistic regression was used to identify factors associated with modern CP use, while controlling simultaneously for independent variables, and accounting for clustering, stratification and sample weights from the complex sampling design. We used random effects meta-analysis to pool adjusted estimates across the 20 countries. RESULTS: The overall prevalence of modern CP use was 26% and ranged from 6% in Guinea to 62% in Zimbabwe. Overall, injectable (32%) was the most preferred method of CP, followed by oral pill (27%) and implants (16%). Women were more likely to use a modern CP if they: had a primary (adjusted prevalence odds ratios (aPORs): 1.68, 95% CI: 1.47 to 1.91)) or secondary/higher education (aPOR: 2.16, 95% CI: 1.80 to 2.59) compared with women with no formal education; had no delivery in the last 2 years (aPOR: 3.89, 95% CI: 2.76 to 5.47) compared with women who delivered in the last 2 years; were aged 25–34 years (aPOR: 1.33, 95% CI: 1.20 to 1.47) compared with women aged 15–24 years; were of middle-income status (aPOR: 1.25, 95% CI: 1.11 to 1.39) or rich (aPOR: 1.53, 95% CI: 1.27 to 1.84) compared with poor women and had two or more antenatal care visits compared with women without a visit. Perceived domestic violence was not associated with modern CP use (aPOR: 0.98, 95% CI: 0.92 to 1.05). CONCLUSION: Our findings are relevant in a global context, particularly in the African region, and improve our understanding on relevant factors essential to increasing modern CP use. BMJ Publishing Group 2020-09-25 /pmc/articles/PMC7520862/ /pubmed/32978208 http://dx.doi.org/10.1136/bmjopen-2020-041103 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Global Health
Apanga, Paschal Awingura
Kumbeni, Maxwell Tii
Ayamga, Emmanuel Awine
Ulanja, Mark B
Akparibo, Robert
Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study
title Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study
title_full Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study
title_fullStr Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study
title_full_unstemmed Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study
title_short Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: a large population-based study
title_sort prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 african countries: a large population-based study
topic Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520862/
https://www.ncbi.nlm.nih.gov/pubmed/32978208
http://dx.doi.org/10.1136/bmjopen-2020-041103
work_keys_str_mv AT apangapaschalawingura prevalenceandfactorsassociatedwithmoderncontraceptiveuseamongwomenofreproductiveagein20africancountriesalargepopulationbasedstudy
AT kumbenimaxwelltii prevalenceandfactorsassociatedwithmoderncontraceptiveuseamongwomenofreproductiveagein20africancountriesalargepopulationbasedstudy
AT ayamgaemmanuelawine prevalenceandfactorsassociatedwithmoderncontraceptiveuseamongwomenofreproductiveagein20africancountriesalargepopulationbasedstudy
AT ulanjamarkb prevalenceandfactorsassociatedwithmoderncontraceptiveuseamongwomenofreproductiveagein20africancountriesalargepopulationbasedstudy
AT akpariborobert prevalenceandfactorsassociatedwithmoderncontraceptiveuseamongwomenofreproductiveagein20africancountriesalargepopulationbasedstudy